Early Phase 1 Ovarian Cancer Trial, Recruiting (NCT07106996)

Early Phase 1 Ovarian Cancer Trial, Recruiting NCT07106996 Sponsor: Sichuan Provincial People's Hospital Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07106996 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between 18 and 40 years old
People who have been diagnosed with polycystic ovary syndrome (PCOS) based on having at least two of the following: irregular or absent ovulation, signs of higher-than-normal male hormones (either through symptoms or blood tests), or an ultrasound showing a specific pattern of small cysts on the ovaries
People who have been fully informed about what the study involves and its risks, and who have agreed to take part voluntarily

Who may not be able to join:

People who are currently pregnant (as confirmed by a urine or blood pregnancy test)
People who have an active infectious disease or serious problems affecting multiple organs in the body
People who have taken antibiotics, probiotics, prebiotics, or other medications that can affect gut bacteria within the 3 months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07106996

Sponsor: Sichuan Provincial People's Hospital

Phase: Early Phase 1

Status: Recruiting

Condition: Ovarian Cancer

More information: https://clinicaltrials.gov/study/NCT07106996

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between 18 and 40 years old
People who have been diagnosed with polycystic ovary syndrome (PCOS) based on having at least two of the following: irregular or absent ovulation, signs of higher-than-normal male hormones (either through symptoms or blood tests), or an ultrasound showing a specific pattern of small cysts on the ovaries
People who have been fully informed about what the study involves and its risks, and who have agreed to take part voluntarily

Who may not be able to join:

People who are currently pregnant (as confirmed by a urine or blood pregnancy test)
People who have an active infectious disease or serious problems affecting multiple organs in the body
People who have taken antibiotics, probiotics, prebiotics, or other medications that can affect gut bacteria within the 3 months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Sichuan Provincial People's Hospital

Registry

ClinicalTrials.gov

Start date

28 July 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

inflammatory marker IL18 [pg/ml]; inflammatory marker IL1β [pg/ml]; testosterone (nmol/l); Follicle - Stimulating Hormone (mIU/mL); Luteinizing Hormone (mIU/mL); Estradiol (pmol/l); Progesterone (ng/mL); Prolactin (ng/mL); follicles number; ovarian volume(Length x Width x Thickness/2,ml); Follicle diameter(mm); Hydroxyindole concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov